GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd., are pleased to announce the presentation of a fully functional, portable medical diagnostic demonstrator on October 11th, at Molecular Vision’s laboratory in London, UK. The standalone platform incorporates organic semiconductor detection technology in a high sensitivity, battery-powered handheld device, complete with LED display and self-referencing capability.
